Research only
CJC-1295 DAC
GHRH analogue with an albumin-binding DAC group
€45.00
- Form
- Lyophilised powder
- Amount
- 5 mg vial
- Purity
- ≥ 99 %
- In stock, ships in 1 business day
- Sealed, moisture-protected packaging
About this product
CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH 1-29) carrying an albumin-binding group (DAC, Drug Affinity Complex). Supplied as a lyophilised powder in a 5 mg vial for laboratory research.
Structure
- Peptide backbone – the GHRH(1-29) sequence with four amino acid substitutions (D-Ala2, Gln8, Ala15, Leu27) that increase resistance to enzymatic degradation.
- DAC group. A maleimidopropionic acid attached to a C-terminal lysine. It binds covalently to serum albumin, so the compound persists far longer in research models than the peptide without DAC.
Research areas
- GHRH receptor binding and activation studies in pituitary cell models.
- Peptide–albumin conjugation and pharmacokinetics.
- Comparison with CJC-1295 without DAC (Mod GRF 1-29) and native GHRH.
Packaging
A sealed glass vial with an aluminium crimp cap. Every vial carries a batch number and expiry date.
For laboratory research only. Not for human or animal use.
- Purity confirmed
- Batch certificate of analysis (COA)
| Purity | ≥ 99 % |
|---|---|
| CAS number | 863288-34-0 |
| Molecular formula | C165H269N47O46 |
| Molecular weight | 3647.2 g/mol |
| Sequence length | 30 aa |
Store at 2–8 °C (−20 °C for long-term storage), dry and away from light. Let the vial reach room temperature before opening.
For in-vitro research use only. Not a medicine or food supplement. Not for human or animal use. Research use policy
